Botulinum Toxin Type-A (BoNT-A) Injections of the Corrugator Muscles for Aesthetics and Depression?

Plast Surg Nurs. 2016 Oct/Dec;36(4):167-169. doi: 10.1097/PSN.0000000000000159.

Abstract

The treatment of glabellar lines with botulinum toxin type-A (BoNT-A) is a staple for aesthetic providers who specialize in facial rejuvenation. Clinical efforts are currently underway to substantiate upper facial injections (the corrugator muscles are the target muscles) of BoNT-A as an antidepression therapy. This article describes the origin of "facial feedback" by Charles Darwin nearly 150 years ago, as well as "emotional proprioception"-2 neuroanatomical concepts that help provide the scientific rationale behind the general influence facial muscles have on the emotional centers of the brain, and, specifically, how the corrugator muscles-involved with frowning-promote a gloomy mood. The journey researchers have taken to clinically qualify BoNT-A injections of the corrugator muscles-to inhibit frowning, and thereby mitigate depression-will also be highlighted so that aesthetic providers are up to date on this emerging benefit of BoNT-A.

MeSH terms

  • Botulinum Toxins, Type A / therapeutic use*
  • Cosmetic Techniques
  • Depression / drug therapy*
  • Facial Expression*
  • Facial Muscles*
  • Humans
  • Injections, Intramuscular
  • Neuromuscular Agents / therapeutic use*
  • Proprioception
  • Rejuvenation
  • Skin Aging

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A